Mika Taylor

Researcher

Last publication 2024 Last refreshed 2026-05-16

unknown

2 h-index 4 pubs 12 cited

Biography and Research Information

OverviewAI-generated summary

Mika Taylor's research at the University of Arkansas for Medical Sciences focuses on developing novel immunotherapies for cancer. Recent publications investigate the repurposing of the live attenuated trivalent MMR vaccine as a cost-effective immunotherapy for cancer. Additionally, Taylor's work explores enhancing immune responses and survival rates in hepatocellular carcinoma through the use of the oncolytic Jurona virus in conjunction with immune checkpoint blockade. This research includes a comprehensive proteogenomic analysis to assess the in vivo safety and immunoactivity of the oncolytic Jurona virus in hepatocellular carcinoma models. Taylor collaborates with researchers including Steven R. Post, Martin J. Cannon, Camila Simões, and Bolni Marius Nagalo, all from the University of Arkansas for Medical Sciences, with whom they have co-authored four publications.

Metrics

  • h-index: 2
  • Publications: 4
  • Citations: 12

Selected Publications

  • Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade (2024)
    4 citations DOI OpenAlex
  • Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy (2022)
    7 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

34 Collaborators 12 Institutions 1 Country

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics